AR039027A1 - Compuesto de los acidos 4-[(8-substituido)-6-cromanoil] y 4-[(8-substituido)-croman-6-il-etinil]-benzoico y fenilacetico, composicion farmaceutica que lo comprende y su uso para prepararla - Google Patents
Compuesto de los acidos 4-[(8-substituido)-6-cromanoil] y 4-[(8-substituido)-croman-6-il-etinil]-benzoico y fenilacetico, composicion farmaceutica que lo comprende y su uso para prepararlaInfo
- Publication number
- AR039027A1 AR039027A1 ARP030100968A ARP030100968A AR039027A1 AR 039027 A1 AR039027 A1 AR 039027A1 AR P030100968 A ARP030100968 A AR P030100968A AR P030100968 A ARP030100968 A AR P030100968A AR 039027 A1 AR039027 A1 AR 039027A1
- Authority
- AR
- Argentina
- Prior art keywords
- substituted
- alkyl
- compound
- integer
- values
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Neurology (AREA)
- Heart & Thoracic Surgery (AREA)
- Virology (AREA)
- Ophthalmology & Optometry (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyrane Compounds (AREA)
Abstract
Un compuesto de los ácidos 4-[(8-sustituido)-6-cromanoil] y 4-[(8-sustituido)-croman-6-il-etinil]-benzoico y fenilacético que tiene la fórmula (1) donde Z es COO o C?C; R1 es alquilo C1-6; R2 es independientemente alquilo C1-6, F, Cl, Br, I, CF3, alquilo sustituido con F, de 1 a 6 carbonos, OH, SH, alcoxi C1-6 o alquiltio C1-6; R3 es independientemente alquilo C1-6, F, Cl, Br, I, CF3, alquilo sustituido con F de 1 a 6 carbonos, OH, SH, alcoxi C1-6 o alquiltio C1-6; m es un entero que tiene los valores de 0 a 6; n es un entero que tiene los valores de 0 a 2; o es un entero que tiene los valores 0 a 4; p es un entero que tiene los valores 1 o 2; Y es CH?C, CH?C-CH2-; CH2=CH- o C?N; R es H, alquilo C1-6, -CH2OR4, CH2-O-COR4, o un catión de una base farmacéuticamente aceptable, y R4 es alquilo C1-6. Una composición farmacéutica que comprende un excipiente farmacéuticamente aceptable y una dosis efectiva de uno o más compuestos según lo reivindicado. Este compuesto tiene actividad inhibitoria del citocromo P450RAI-I y P450RAI-2, y son adecuados para el tratamiento de los mamíferos con condiciones que son tratables con retinoides, o que están controlados por lo que responden al ácido retinoico nativo del organismo. La formulaciones que contienen los compuestos de la presente pueden también ser co-administrados con retinoides y/o Vitamina A para aumentar o prolongar los efectos de las medicaciones que contienen retinoides, vitamina A o el ácido retinoico nativo del organismo.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/100,638 US6740676B2 (en) | 2002-03-19 | 2002-03-19 | 4-[(8-ethynyl, 8-vinyl or 8-ethynyl-methyl)-6-chromanoyl]-benzoic and 2-[4-[(8-ethynyl, 8-vinyl or 8-ethynyl-methyl)-6-chromanoyl]-phenyl]-acetic acid, their esters and salts having cytochrome p450rai inhibitory activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR039027A1 true AR039027A1 (es) | 2005-02-02 |
Family
ID=28452321
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP030100968A AR039027A1 (es) | 2002-03-19 | 2003-03-19 | Compuesto de los acidos 4-[(8-substituido)-6-cromanoil] y 4-[(8-substituido)-croman-6-il-etinil]-benzoico y fenilacetico, composicion farmaceutica que lo comprende y su uso para prepararla |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US6740676B2 (es) |
| EP (1) | EP1485368A1 (es) |
| JP (1) | JP2005525387A (es) |
| CN (1) | CN1656088A (es) |
| AR (1) | AR039027A1 (es) |
| AU (1) | AU2003213848B2 (es) |
| BR (1) | BR0308576A (es) |
| CA (1) | CA2478913A1 (es) |
| IL (1) | IL164103A0 (es) |
| MX (1) | MXPA04009046A (es) |
| TW (1) | TW200305399A (es) |
| WO (1) | WO2003080594A1 (es) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040077721A1 (en) * | 2002-03-19 | 2004-04-22 | Yang-Dar Yuan | Compositions and methods using compounds having cytochrome P450RAI inhibitory activity co-administered with vitamin A |
| US6740676B2 (en) * | 2002-03-19 | 2004-05-25 | Allergan, Inc. | 4-[(8-ethynyl, 8-vinyl or 8-ethynyl-methyl)-6-chromanoyl]-benzoic and 2-[4-[(8-ethynyl, 8-vinyl or 8-ethynyl-methyl)-6-chromanoyl]-phenyl]-acetic acid, their esters and salts having cytochrome p450rai inhibitory activity |
| DK1842557T3 (da) | 2004-12-22 | 2013-12-02 | Nitto Denko Corp | Lægemiddelbærer og lægemiddelbærerkit til inhibition af fibrose |
| JP2009221164A (ja) * | 2008-03-17 | 2009-10-01 | Nitto Denko Corp | 肺線維症処置剤 |
| US20120269886A1 (en) | 2004-12-22 | 2012-10-25 | Nitto Denko Corporation | Therapeutic agent for pulmonary fibrosis |
| US9572886B2 (en) | 2005-12-22 | 2017-02-21 | Nitto Denko Corporation | Agent for treating myelofibrosis |
| KR100801029B1 (ko) | 2005-12-27 | 2008-02-04 | 제일모직주식회사 | 디아민 화합물 및 이를 이용한 액정 배향제 |
| US20070185055A1 (en) * | 2006-02-06 | 2007-08-09 | Guang Liang Jiang | Method for treating cachexia with retinoid ligands |
| WO2009070744A1 (en) * | 2007-11-28 | 2009-06-04 | Sequoia Pharmaceuticals, Inc. | Compositions and methods for inhibiting cytochrome p450 2d6 |
| TWI407971B (zh) | 2007-03-30 | 2013-09-11 | Nitto Denko Corp | Cancer cells and tumor-related fibroblasts |
| CN111233809B (zh) * | 2020-01-16 | 2021-12-03 | 广东省中医院（广州中医药大学第二附属医院、广州中医药大学第二临床医学院、广东省中医药科学院） | 一种Millepachine-CA-4衍生物及其制备方法和应用 |
| WO2023190164A1 (ja) * | 2022-03-28 | 2023-10-05 | 日油株式会社 | アリールエステルを含むカルボン酸の製造方法及びカチオン性脂質の製造方法 |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH651034A5 (de) | 1982-05-12 | 1985-08-30 | Hoffmann La Roche | Chroman-, thiochroman- oder 1,2,3,4-tetrahydrochinolinderivate und ihre verwendung als arzneimittel-wirkstoffe. |
| EP0130795B1 (en) | 1983-07-05 | 1988-11-23 | Pfizer Inc. | Carboxylic acid derivatives useful for inhibiting the degradation of cartilage |
| EP0155940A1 (en) | 1983-08-08 | 1985-10-02 | Sri International | Benzonorbornenyl, benzopyranyl and benzothiopyranyl retinoic acid analogues |
| DE3563447D1 (en) * | 1984-03-28 | 1988-07-28 | Asahi Chemical Ind | Process for producing polyether polyol, the produced polyether polyol and polyurethane |
| US4826984A (en) | 1984-04-09 | 1989-05-02 | The Board Of Regents For The Oklahoma Agricultural And Mechanical College Acting For And On Behalf Of Oklahoma State University | Heteroarotinoid compounds as anticancer agents |
| LU86351A1 (fr) | 1986-03-12 | 1987-11-11 | Oreal | Composes benzopyrannyl et benzothiopyrannyl benzoiques,leur procede de preparation et leur utilisation en cosmetique et en medecine humaine et veterinaire |
| US5149705A (en) | 1987-03-13 | 1992-09-22 | Allergan, Inc. | Acetylenes disubstituted with a heteroaromatic group and a tetralin group and having retinoid like activity |
| US5264578A (en) | 1987-03-20 | 1993-11-23 | Allergan, Inc. | Disubstituted acetylenes bearing heterobicyclic groups and heteroaromatic or phenyl groups having retinoid like activity |
| US5089509A (en) | 1988-09-15 | 1992-02-18 | Allergan, Inc. | Disubstituted acetylenes bearing heteroaromatic and heterobicyclic groups having retinoid like activity |
| AU626881B2 (en) | 1988-07-14 | 1992-08-13 | F. Hoffmann-La Roche Ag | Benzofused heterocyclics used as pharmaceuticals |
| US5023341A (en) | 1989-09-19 | 1991-06-11 | Allergan, Inc. | Compounds having a disubstituted acetylene moiety and retinoic acid-like biological activity |
| US5399561A (en) | 1989-09-19 | 1995-03-21 | Allergan, Inc. | Acetylenes disubstituted with a phenyl or heteroaryl group and a 2-oxochromanyl, 2-oxothiochromanyl or 2-oxo-1,2,3,4-tetrahydro-quinolinyl group having retinoid-like biological activity |
| US4980369A (en) | 1989-09-19 | 1990-12-25 | Allergan, Inc. | Acetylenes disubstituted with a phenyl group and a 2-substituted chromanyl or thiochromanyl group having retinoid-like activity |
| US5045551A (en) | 1989-09-19 | 1991-09-03 | Allergan, Inc. | Acetylenes disubstituted with a heteroaromatic group and a 2-substituted chromanyl, thiochromanyl or 1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity |
| US5006550A (en) * | 1989-12-29 | 1991-04-09 | Allergan, Inc. | Chroman esters of phenols and benzoic acids having retinoid-like activity |
| JPH06501948A (ja) * | 1990-10-09 | 1994-03-03 | アラーガン、インコーポレイテッド | レチノイド様活性を有するクロマンおよびチオクロマン |
| CA2101160A1 (en) | 1991-02-13 | 1992-08-14 | Roshantha A. Chandraratna | Chroman and thiochromans with phenylethynyl substituents at the 7-position having retinoid-like biological activity |
| AU652830B2 (en) | 1991-03-26 | 1994-09-08 | Allergan, Inc. | Chromans and thiochromans with heteroarylethynyl substituents at the 7-position having retinoid-like biological activity |
| US5134159A (en) | 1991-03-26 | 1992-07-28 | Allergan, Inc. | 7-chromanyl esters of phenols and benzoic acids having retinoid-like activity |
| AU679171B2 (en) | 1991-12-18 | 1997-06-26 | Baylor College Of Medicine | Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor |
| US5466861A (en) | 1992-11-25 | 1995-11-14 | Sri International | Bridged bicyclic aromatic compounds and their use in modulating gene expression of retinoid receptors |
| JPH08511027A (ja) | 1993-01-11 | 1996-11-19 | リガンド・ファーマシューティカルズ・インコーポレーテッド | レチノイドｘレセプターに対して選択的な活性を有する化合物、およびレチノイドｘレセプターによって媒体されたプロセスの調節手段 |
| US5455265A (en) | 1993-02-11 | 1995-10-03 | Allergan, Inc. | Method of treatment with compounds having selective agonist-like activity on RXR retinoid receptors |
| US5675024A (en) | 1995-11-22 | 1997-10-07 | Allergan | Aryl or heteroaryl amides of tetrahydronaphthalene, chroman, thiochroman and 1,2,3,4,-tetrahydroquinoline carboxylic acids, having an electron withdrawing substituent in the aromatic or heteroaromatic moiety, having retinoid-like biological activity |
| US5965606A (en) | 1995-12-29 | 1999-10-12 | Allergan Sales, Inc. | Methods of treatment with compounds having RAR.sub.α receptor specific or selective activity |
| US6864367B2 (en) * | 2000-02-21 | 2005-03-08 | Takeda Chemical Industries, Ltd. | Process for producing cyclic compound |
| AU2001279687B2 (en) * | 2000-06-30 | 2005-02-24 | Unilever Plc | Skin conditioning compositions containing compounds for mimicking the effect on skin of retinoic acid |
| CA2420869A1 (en) * | 2000-08-29 | 2002-03-07 | Allergan, Inc. | Compounds having activity as inhibitors of cytochrome p450rai |
| US6252090B1 (en) * | 2000-08-29 | 2001-06-26 | Allergan Sales, Inc. | Compounds having activity as inhibitors of cytochrome P450RAI |
| US6313107B1 (en) | 2000-08-29 | 2001-11-06 | Allergan Sales, Inc. | Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI |
| US6303785B1 (en) | 2000-08-29 | 2001-10-16 | Allergan Sales, Inc. | Compounds having activity as inhibitors of cytochrome P450RAI |
| US20040077721A1 (en) * | 2002-03-19 | 2004-04-22 | Yang-Dar Yuan | Compositions and methods using compounds having cytochrome P450RAI inhibitory activity co-administered with vitamin A |
| US6740676B2 (en) * | 2002-03-19 | 2004-05-25 | Allergan, Inc. | 4-[(8-ethynyl, 8-vinyl or 8-ethynyl-methyl)-6-chromanoyl]-benzoic and 2-[4-[(8-ethynyl, 8-vinyl or 8-ethynyl-methyl)-6-chromanoyl]-phenyl]-acetic acid, their esters and salts having cytochrome p450rai inhibitory activity |
-
2002
- 2002-03-19 US US10/100,638 patent/US6740676B2/en not_active Expired - Fee Related
-
2003
- 2003-03-11 EP EP03711542A patent/EP1485368A1/en not_active Withdrawn
- 2003-03-11 BR BR0308576-7A patent/BR0308576A/pt not_active Application Discontinuation
- 2003-03-11 AU AU2003213848A patent/AU2003213848B2/en not_active Ceased
- 2003-03-11 MX MXPA04009046A patent/MXPA04009046A/es active IP Right Grant
- 2003-03-11 IL IL16410303A patent/IL164103A0/xx unknown
- 2003-03-11 CA CA002478913A patent/CA2478913A1/en not_active Abandoned
- 2003-03-11 WO PCT/US2003/007612 patent/WO2003080594A1/en not_active Ceased
- 2003-03-11 CN CNA038114283A patent/CN1656088A/zh active Pending
- 2003-03-11 JP JP2003578348A patent/JP2005525387A/ja active Pending
- 2003-03-14 US US10/389,071 patent/US7351737B2/en not_active Expired - Fee Related
- 2003-03-19 TW TW092106025A patent/TW200305399A/zh unknown
- 2003-03-19 AR ARP030100968A patent/AR039027A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1656088A (zh) | 2005-08-17 |
| AU2003213848A1 (en) | 2003-10-08 |
| EP1485368A1 (en) | 2004-12-15 |
| BR0308576A (pt) | 2005-01-04 |
| IL164103A0 (en) | 2005-12-18 |
| WO2003080594A1 (en) | 2003-10-02 |
| TW200305399A (en) | 2003-11-01 |
| US20030191181A1 (en) | 2003-10-09 |
| MXPA04009046A (es) | 2005-06-08 |
| US20030207937A1 (en) | 2003-11-06 |
| AU2003213848B2 (en) | 2007-08-16 |
| US7351737B2 (en) | 2008-04-01 |
| US6740676B2 (en) | 2004-05-25 |
| CA2478913A1 (en) | 2003-10-02 |
| JP2005525387A (ja) | 2005-08-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR039027A1 (es) | Compuesto de los acidos 4-[(8-substituido)-6-cromanoil] y 4-[(8-substituido)-croman-6-il-etinil]-benzoico y fenilacetico, composicion farmaceutica que lo comprende y su uso para prepararla | |
| AR046297A1 (es) | Inhibidores de la dpp - iv metodos para prepararlos y composiciones farmaceuticas que los contienen como agente activo | |
| PE20251288A1 (es) | Compuestos heterociclicos como inmunomoduladores | |
| AR017021A1 (es) | Acido 2-hidroxiacetico | |
| RU2007142328A (ru) | Производные тиоксантина в качестве ингибиторов миелопероксидазы | |
| AR036114A1 (es) | Tetrahidroimidazol[1,2-a]pirazinas y tetrahidrotriazol[4,3-a]pirazinas como inhibidores de la dipeptidil peptidasa utiles para el tratamiento o la prevencion de la diabetes | |
| ECSP066653A (es) | Derivados de bencenosulfonilamino-piridin-2-il y compuestos relacionados como inhibidores de 11-beta-hidroxiesteroide deshidrogenasa tipo 1(ii-beta-hsd-1) para el tratamiento de la diabetes y de la obesidad | |
| CA2099232A1 (en) | Fluoro taxols | |
| EA200301216A1 (ru) | Замещенные хинуклидинами мультициклические гетероарилы для лечения заболевания | |
| DE60325830D1 (de) | Substituiertes phenylalkansäurederivat und dessen verwendung | |
| AR033335A1 (es) | Compuestos de acidos 3-propil gama aminobutirico mono y di sustituidos, composicion farmaceutica que los comprende y su uso para fabricar dicha composicion | |
| RU2006119776A (ru) | Производные бензо{b}{1, 4} диоксепина | |
| RU2007118727A (ru) | Ингибиторы mif | |
| PT1216245E (pt) | Derivados sulfonil-hidrazida farmaceuticamente activos | |
| WO2009085695A1 (en) | Treatment or prevention of skin injury due to exposure to ultraviolet light | |
| PE20050293A1 (es) | Derivados de aminoacidos sustituidos con cicloalquilo, procedimiento para su preparacion y su uso como medicamentos | |
| HU9301902D0 (en) | Fluorinic derivatives of taxole, method for producing them and anti-cancer preparatives containing said compounds as active agent | |
| PE20021060A1 (es) | Empleo de amidas de acidos antranilicos como medicamento para el tratamiento de arritmias, asi como preparados farmaceuticos que las contienen | |
| NO20020523L (no) | Nye 2-dekarboksy-2-fosfinikoprostaglandin F-analoger | |
| BR0008776A (pt) | Análogos de prostaglandinas fp-seletivosinsaturados c16 | |
| BR0008778A (pt) | Análogos de prostaglandinas seletivos para fpc16 insaturados | |
| AR036351A1 (es) | Isoxazolopiridinonas, el uso de las mismas para la fabricacion de un medicamento, composiciones y combinaciones farmaceuticas | |
| JP2005525387A5 (es) | ||
| PE20250781A1 (es) | Composicion farmaceutica y que comprende derivados de difenildiazol metodos de uso | |
| AR128100A1 (es) | Compuestos para el tratamiento de la pérdida del cabello |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |